Chronic Myelomonocytic Leukemia

DBCOND0028572Hemic and Lymphatic DiseasesNeoplasms

Chronic Myelomonocytic Leukemia is the indication for 3 drugs in DrugBank. It is covered by 4 curated, structured indications.

Also known as
Chronic myelomonocytic leukaemia · Chronic Myelomonocytic Leukemia (CMML) · CMML · Leukemia Myelomonocytic Chronic
Classified under
Indicated drugs

Resolves to

Vocabularies
ICD-10C93.1SNOMED CT127225006MedDRA10009000UMLSC0023466

What you can answer from here — as of October 05, 2026

3Indicated drugsWith each drug's targets and mechanism
Listed above
4Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
303Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Chronic Myelomonocytic Leukemia share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In